Sign in
4/A

Changes in Ownership

Cue Biopharma, Inc. Filed Acc 0001209191-20-045921

SVP, General Counsel and Sec sold 13,374 shares at $20.00 ($267,480)

  • SVP, General Counsel and Sec acquired 13,374 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sandercock Colin SVP, General Counsel and Sec 2020-08-05 Option exercise +13,374 $7.50 $100,305 30,499 D: show line 1 in the form
Sandercock Colin SVP, General Counsel and Sec 2020-08-05 Sale −13,374 $20.00 $267,480 17,125 D: show line 2 in the form
Open-market sales · 13,374 sh · avg $20.00 · $267,480

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Sandercock Colin SVP, General Counsel and Sec 2020-08-05 Option exercise · Stock Option (right to buy) −13,374 130,000 D: show line 3 in the form
Loading xslF345X03/doc4a.xml…